Ahmed Shelbaya

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Ejection Fraction

Chronic Lymphocytic Leukemia

Top Venues

ClinicoEconomics and outcomes research : CEOR

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Grace E Fox, Mark Bernauer, Jennifer M Stephens, Bianca Jackson, Joshua A Roth, Ahmed Shelbaya
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Grace E Fox, Mark Bernauer, Jennifer M Stephens, Bianca Jackson, Joshua A Roth, Ahmed Shelbaya
Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Ahmed Shelbaya, John M Kelton, Jeffrey Thompson, Jose Mj Alvir, Martine C Maculaitis, Jingyan Yang
Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA. Future oncology (London, England) 17 (30) (2021)